W e last offered our ideas on the role of reverse EC coupling in the initiation of arrhythmias in 2001. 1 At that time we emphasized that spurious Ca 2ϩ release or oscillations in Ca 2ϩ levels could serve as possible triggers for arrhythmias. Since then much has been done to confirm this role for intracellular Ca 2ϩ .
At that time we did not discuss the role of Ca 2ϩ cycling in the maintenance or conversion of stable tachycardias to VF. However, in consideration of the new data on the role of APD restitution in the initiation of VF (increase in wavebreaks; eg, see Garfinkel et al 2 ), we turn our attention now to the role Ca 2ϩ cycling in the myocyte and its impact on APD restitution relations in the isolated rabbit ventricular cell. 3 Goldhaber et al consider the role of Ca 2ϩ using different types of APD restitution protocols to emphasize the dynamic nature of intracellular Ca 2ϩ changes and its subsequent impact on the myocyte APD.
In their study APD alternans is coupled to Ca 2ϩ cycling, which in itself is not new since others have observed that APD alternans demonstrates a hystersis and is inhibited with BAPTA-AM buffering. 4 Some have suggested that repolarization alternans is more closely associated with Ca 2ϩ than APD restitution. [5] [6] [7] In fact there has been a large body of work implying that APD alternans and Ca 2ϩ cycling are intimately linked (eg, see 8, 9 ) . However caution must be raised because Chudin et al 10 have reported that the dynamics of Ca i are altered even when an AP clamp waveform is used. Although the Chudin data may have little relation to the AP dynamics and Ca 2ϩ cycling of normal ventricular myocytes (such as those used in the study of Goldhaber), they may well contribute to our understanding of the dynamics of Ca i cycling in the highly remodeled myocyte where little or no frequency-dependent APD shortening exists due to remodeled potassium channels (eg, epicardial border zone cells).
An important conclusion of Goldhaber and his colleagues is that it is the accumulation of myocyte Ca 2ϩ (measured here as a FURA2 ratio) that contributes to the appearance of APD alternans (see Figures 1B and 3B 3 ). Although not measured in these experiments, others have aligned these Ca 2ϩ changes with intracellular Na ϩ accumulation. 11 A recent model that takes into account the spatially (subcellular) localized nature of Ca 2ϩ release events shows a steep relation between SR release, diastolic calcium, and Ca 2ϩ -dependent inactivation of I CaL . 12 The time course of decay of the experimentally observed Ca 2ϩ transient in some ways can predict the Ca 2ϩ accumulation seen during rapid pacing. In fact, choice of dye to measure such changes may affect this outcome. Recently two photon studies have shown clearly that Ca 2ϩ transients in Rhod2-loaded cells decay faster than those in FURA2-loaded cells 13 suggesting that Ca 2ϩ alternans would be seen in FURA2-loaded cells well before Rhod2 cells. Finally, onset of Ca 2ϩ alternans is related to the underlying nature of the Ca 2ϩ release processes. In the normal guinea pig heart, spatial heterogeneity of intrinsic cell function exists with LV basal area cells showing longer and smaller Ca 2ϩ transients than those of the apex. 14 Interestingly, this is the same area that is prone to Ca 2ϩ alternans but not where APD restitution is the steepest. 5 In Goldhaber et al, 3 treatment of cells with ryanodine/ thapsigargin eliminated alternans and affected the APD restitution curves appropriately (flattened them). Although not necessarily a cause and an effect, it shows proof of the principle in that blocking Ca 2ϩ release and uptake has an effect on APD alternans/restitution. Was there less Ca 2ϩ accumulation with drug during such protocols? This is difficult to state because studies such as those depicted in Figure 3B 3 were not reported for drug protocols.
On the other hand, treatment of single cells with BAPTA-AM (or putting BAPTA salt in the cAMP containing pipette solution) also abolished APD alternans but failed to flatten APD restitution curves. Again there is a disconnect between APD restitution parameters and alternans consistent with the studies of Pruvot et al. 5 As discussed by the authors, their data suggest that just by buffering diastolic Ca 2ϩ changes one may not achieve the required antifibrillatory effectiveness (if the flattening of the APD restitution curve is a goal of therapy). However, it is not clear what effect of BAPTA had on Ca 2ϩ cycling in these experiments. Did it eliminate Ca i accumulation during the protocols? In particular did it buffer Ca 2ϩ in the microdomain between sarcolemmal channels and the SR?
It is highly likely that the Ca 2ϩ cycling effects resulting from the BAPTA maneuvers were not similar to those of the ryanodine/thapsigargin experiments. BAPTA by virtue of its If there is such an important relationship between Ca 2ϩ cycling and the occurrence of APD alternans, then should we begin to consider focusing on this point as antiarrhythmic (antifibrillatory) therapy? Most certainly. However, currently approved antiarrhythmics already include drugs that affect Ca 2ϩ cycling, and they don't seem to be useful (eg, the pore channel blocker verapamil). Perhaps we need drugs that are more selective in their perturbation of the Ca 2ϩ cycling system; drugs that normalize Ca 2ϩ turnover, ones that normalize Ca 2ϩ dependent protein actions, others that normalize channel changes brought about by Ca 2ϩ ion, and finally ones that normalize cardiac mechanics if nonuniform tissues are involved (which of course is not the case in Goldhaber et al where normal single cells are used). Examples here might include drugs that affect CaMKII function (see Anderson 15 ), agents that are highly specific for critical Ca 2ϩ dependent ion channels (such as apamin sensitive SK2 channels recently functionally and molecularly described in mouse and human atria 16 ).
